Correlation Between Novo Nordisk and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Novo Nordisk and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and PsyBio Therapeutics.
Diversification Opportunities for Novo Nordisk and PsyBio Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Novo and PsyBio is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between Novo Nordisk and PsyBio Therapeutics
Considering the 90-day investment horizon Novo Nordisk is expected to generate 36.41 times less return on investment than PsyBio Therapeutics. But when comparing it to its historical volatility, Novo Nordisk AS is 23.31 times less risky than PsyBio Therapeutics. It trades about 0.03 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 5.29 in PsyBio Therapeutics Corp on October 16, 2024 and sell it today you would lose (5.28) from holding PsyBio Therapeutics Corp or give up 99.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Novo Nordisk AS vs. PsyBio Therapeutics Corp
Performance |
| Timeline |
| Novo Nordisk AS |
| PsyBio Therapeutics Corp |
Novo Nordisk and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and PsyBio Therapeutics
The main advantage of trading using opposite Novo Nordisk and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
| PsyBio Therapeutics vs. Novo Nordisk AS | PsyBio Therapeutics vs. Novo Nordisk AS | PsyBio Therapeutics vs. Vertex Pharmaceuticals | PsyBio Therapeutics vs. CSL |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |